home / stock / imvt / imvt short
Short Information | Immunovant Inc. (NASDAQ:IMVT)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,597,388 |
Total Actual Volume | 23,369,350 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 179,869 |
Average Short Percentage | 16.26% |
Is there a IMVT Short Squeeze or Breakout about to happen?
See the IMVT Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $27.51 | $26.52 | $27.84 | $26.25 | 625,082 | 116,778 | 18.68% |
07-01-2024 | $26.39 | $27.51 | $28.64 | $26.26 | 1,383,102 | 195,729 | 14.15% |
06-28-2024 | $26.13 | $26.4 | $26.58 | $25.59 | 1,743,676 | 114,010 | 6.54% |
06-27-2024 | $26.14 | $26 | $26.37 | $25.82 | 794,067 | 124,257 | 15.65% |
06-26-2024 | $27.09 | $26.06 | $27.19 | $25.865 | 1,469,197 | 285,962 | 19.46% |
06-25-2024 | $27.22 | $27.29 | $27.54 | $26.97 | 882,471 | 108,830 | 12.33% |
06-24-2024 | $27.39 | $27.37 | $28.46 | $27.35 | 988,151 | 164,451 | 16.64% |
06-21-2024 | $27.46 | $27.32 | $27.71 | $26.76 | 3,134,679 | 286,779 | 9.15% |
06-20-2024 | $25.88 | $27.29 | $27.31 | $25.87 | 1,020,101 | 227,092 | 22.26% |
06-18-2024 | $26.77 | $26.19 | $27.25 | $26.09 | 1,007,673 | 211,128 | 20.95% |
06-17-2024 | $25.89 | $26.8 | $27.07 | $25.7 | 1,205,600 | 209,822 | 17.4% |
06-14-2024 | $26.35 | $26 | $26.55 | $25.61 | 965,996 | 172,616 | 17.87% |
06-13-2024 | $25.41 | $26.6 | $26.67 | $25.19 | 1,084,624 | 214,782 | 19.8% |
06-12-2024 | $25.7 | $25.56 | $26.09 | $25.39 | 714,553 | 123,872 | 17.34% |
06-11-2024 | $25.24 | $25.1 | $25.39 | $24.7 | 1,198,443 | 166,401 | 13.88% |
06-10-2024 | $24.98 | $25.41 | $25.465 | $24.67 | 1,149,577 | 161,822 | 14.08% |
06-07-2024 | $25.28 | $25.17 | $25.84 | $24.94 | 874,722 | 77,385 | 8.85% |
06-06-2024 | $25.4 | $25.43 | $25.9 | $25.15 | 1,085,636 | 282,032 | 25.98% |
06-05-2024 | $25.34 | $25.6 | $26.25 | $25.01 | 961,285 | 126,506 | 13.16% |
06-04-2024 | $25.09 | $25.23 | $26.01 | $24.9 | 1,080,715 | 227,134 | 21.02% |
News, Short Squeeze, Breakout and More Instantly...
2024-06-12 13:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic areas over this fiscal year ending March 31, 2025 Topline data from the bato...
2024-05-29 14:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for IMVT on May 29, 2024 12:26PM ET. The previous analyst recommendation was Neutral. IMVT was trading at $30.615 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...